iTeos Therapeutics Inc. (ITOS) Social Stream

Featured Post From StockTwits About ITOS

$ITOS The coference call at 8AM is going to be very interesting. The $625M from GSK is non-refundable and as far as I can tell there is no remaining performance obligation. This works out to about $17.80 revenue per share that I think will hit the 3rd quarter financials. As of June 30, the company has about $26.43 cash per share. Let's see what analysts do with this and what 3rd quarter EPS estimates are.